Dr Louise  J Michaelis, BSc Hons, MBChB, MRCPCH, MSc, PhD - Great North Children's Hospital - Consultant in Paediatric Immunology and Allergy

Dr Louise J Michaelis

BSc Hons, MBChB, MRCPCH, MSc, PhD

Great North Children's Hospital

Consultant in Paediatric Immunology and Allergy

Newcastle upon Tyne, Tyne and Wear | United Kingdom

Main Specialties: Allergy & Immunology

Additional Specialties: Immunology and Allergy

ORCID logohttps://orcid.org/0000-0001-8229-154X


Top Author

Dr Louise  J Michaelis, BSc Hons, MBChB, MRCPCH, MSc, PhD - Great North Children's Hospital - Consultant in Paediatric Immunology and Allergy

Dr Louise J Michaelis

BSc Hons, MBChB, MRCPCH, MSc, PhD

Introduction

Dr Louise Michaelis is a Consultant and Associate lecturer in Paediatric Immunology and Allergy at The Great North Children’s Hospital Newcastle upon Tyne in the United Kingdom. She has previously worked at Imperial College Healthcare NHS Trust, Great Ormond Street Hospital and Southampton University Hospitals NHS Foundation Trust where she developed an interest in Multi-system Allergic Inflammatory Disease in Children and orchestrates clinics collaboratively with other specialities (atopic dermatitis, IgE and Non IgE-mediated food allergy, allergic asthma and allergic rhinoconjunctivitis). She currently works within a busy Tertiary Paediatric Allergy Service which provides a drug allergy (desensitisation) and immunotherapy (sublingual and subcutaneous) service for children.
Dr Michaelis is currently co-ordinating phase I, II and III MCRN Portfolio clinical trials and has started to evolve and publish a diverse research portfolio as part of her PhD under Prof Graham Roberts and Prof Hasan Arshad, which focuses on the immune and inflammatory mechanisms of tolerance in multi-system allergy in childhood. In February 2016 she was awarded an “NIHR Leading Principle Investigators Award” for her leadership of a Collaborative International Industry and Clinical Trials and in 2017 "The NIHR NENC Commercial Clinical Trial Team of the year Award" continues to bring both Industry and Clinical forums together in research. In 2017 the team was awarded the Bright Ideas in Health Award" for the MoSAIC Honeycomb Model of Seamless Care. She lectures on multisystem allergic inflammatory disease and the recent ASSIGN Study – An amino acid-based formula including specific synbiotics modifies the gut microbiota and reduces clinical symptoms in non-IgE-mediated cow’s milk allergic infants.
Dr Michaelis also participates in both undergraduate and postgraduate teaching forums having written her first book “Total revision – Extended Paediatrics” alongside Dr Ian Maconochie in 2005. She participates in teaching at The Great North Children’s Hospital and lectures as part of Faculty for the Allergy eModule at The University of Newcastle and the Allergy MSc Course at The University of Southampton.

Primary Affiliation: Great North Children's Hospital - Newcastle upon Tyne, Tyne and Wear , United Kingdom

Specialties:

Additional Specialties:

Research Interests:

Metrics

Number of Publications

9

Publications

Number of Profile Views

1071

Profile Views

Number of Article Reads

192

Reads

Number of Citations

38

Citations

Education

Feb 2018
Southampton University
PhD
Apr 2013
Newcastle upon Tyne Hospitals NHS Foundation Trust
Consultant
Apr 2013
University of Newcastle
Associate Lecturer
Jan 2008
University of Southampton
Clinical Research Fellow locum consultant
Jul 2007
University College London
MSc
Jul 2003
Royal College Paediatrics
RCPCH
Jul 1994
Edinburgh University
MBChB
Jul 1989
St Andrews University
BSc(Hons)

Experience

May 2018
TEMPO Clinical Trial
Chief Investigator UK
May 2018
Immune Tolerance in Early Childhood
Co-Investigator
May 2018
Mite Antigen Prevention Clinical Trial
Co-Investigator
May 2018
PRESTO Clinical Trial
Chief Investigator UK
May 2018
BREAD Clinical Trial
Chief Investigator
Nov 2017
Bright Ideas In health Award North East
Clinical Team Lead
Apr 2017
NIHR Industry and Commercial Clinical Trial Team Award
Chief and principle Investigator
Jul 2016
NIHR Principle Investigator Award
Chief Investigator ASSIGN
Oct 2015
ASSIGN Clinical Trial
Chief Investigator
Apr 2013
SNIFFLE I,II,IV clinical Trial
Priniciple Investigator

Publications

9Publications

192Reads

38PubMed Central Citations

An interpretation pf the new international MAP guideline for the management of milk allergy in Primary care

Clinical translational allergy 2017 7:34

Clinical Translational allergy

View Article
September 2017
50 Reads

Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood.

J Allergy Clin Immunol 2015 Dec 12;136(6):1541-1547.e11. Epub 2015 Jun 12.

NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; Clinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom; David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, United Kingdom; Department of Respiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom. Electronic address:

View Article
December 2015
29 Reads
12 Citations
11.480 Impact Factor

Dietary restriction causing iodine-deficient goitre.

Arch Dis Child 2015 Aug 11;100(8):784-6. Epub 2015 Jun 11.

Department of Paediatric Immunology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.

View Article
August 2015
23 Reads
2.900 Impact Factor

Manifestations of food protein induced gastrointestinal allergies presenting to a single tertiary paediatric gastroenterology unit.

World Allergy Organ J 2013 Aug 6;6(1):13. Epub 2013 Aug 6.

Department of Gastroenterology, Great Ormond Street Children's Hospital, Great Ormond Street, London WC1N 3JH, UK.

View Article
August 2013
28 Reads
7 Citations

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.

Pediatr Infect Dis J 2013 Jun;32(6):675-81

Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

View Article
June 2013
37 Reads
2 Citations
2.720 Impact Factor